Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graves' Orbitopathy”

185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 185 results

Large-scale testing (Phase 3)Study completedNCT06269393
What this trial is testing

IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Peking University People's Hospital 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06769984
What this trial is testing

SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.

Who this might be right for
TED
Sinocelltech Ltd. 100
Large-scale testing (Phase 3)Study completedNCT03461211
What this trial is testing

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

Who this might be right for
Thyroid Eye Disease
Amgen 51
Post-approval studies (Phase 4)Study completedNCT00312325
What this trial is testing

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans

Who this might be right for
Regional Blood FlowOptic Disk
Medical University of Vienna 24
Large-scale testing (Phase 3)Ended earlyNCT06307613
What this trial is testing

Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
argenx 102
Testing effectiveness (Phase 2)Study completedNCT03922321
What this trial is testing

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Who this might be right for
Graves' Ophthalmopathy
Immunovant Sciences GmbH 7
Large-scale testing (Phase 3)Looking for participantsNCT06392906
What this trial is testing

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Who this might be right for
Thyroid Associated Ophthalmopathy
Janjira Petsuksiri 68
Large-scale testing (Phase 3)UnknownNCT04776993
What this trial is testing

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

Who this might be right for
Graves' Orbitopathy
University of Pisa 52
Not applicableLooking for participantsNCT06359795
What this trial is testing

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Peking University Third Hospital 50
Not applicableLooking for participantsNCT07124572
What this trial is testing

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Second Affiliated Hospital, School of Medicine, Zhejiang University 500
Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64
Testing effectiveness (Phase 2)Study completedNCT03110848
What this trial is testing

Effects of Atorvastatin in Graves' Orbitopathy (GO)

Who this might be right for
Thyroid Associated OphthalmopathyHypercholesterolemia
University of Pisa 88
Not applicableLooking for participantsNCT06275373
What this trial is testing

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

Who this might be right for
Thyroid Eye DiseaseGraves OphthalmopathyGraves Disease
Walter Reed National Military Medical Center 100
Not applicableLooking for participantsNCT07381413
What this trial is testing

Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid Associated OphthalmopathiesEye Tracking
Shanghai Changzheng Hospital 100
Not applicableEnrolling By InvitationNCT07332988
What this trial is testing

Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves Disease

Who this might be right for
Dry Eye Disease (DED)Graves Ophthalmopathy
Grigore T. Popa University of Medicine and Pharmacy 30
Not applicableLooking for participantsNCT05112211
What this trial is testing

Multi-model Image of Doxycycline in TAO

Who this might be right for
Thyroid Associated Ophthalmopathy
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Ended earlyNCT02845336
What this trial is testing

Celecoxib for Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Johns Hopkins University 7
Not applicableLooking for participantsNCT06367517
What this trial is testing

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Who this might be right for
Orbitopathy, GravesThyroid Eye DiseaseOphthalmopathy
Medical University of Warsaw 30
Early research (Phase 1)Study completedNCT06389578
What this trial is testing

TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Amgen 16
Not applicableStudy completedNCT03590080
What this trial is testing

Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

Who this might be right for
Graves DiseaseGraves OphthalmopathyHypertension+2 more
Medical University of Warsaw 32
Load More Results